Key Financial Data Of Reporting Company

Kringle Pharma,Inc. - Filing #7357145

Concept As at
2023-12-31
2023-10-01 to
2023-12-31
2022-10-01 to
2023-09-30
As at
2023-09-30
As at
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
18,690,000 JPY
69,250,000 JPY
17,365,000 JPY
Ordinary profit (loss)
-169,113,000 JPY
-852,660,000 JPY
-157,476,000 JPY
Profit (loss)
-169,486,000 JPY
-854,151,000 JPY
-157,849,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
354,595,000 JPY
97,546,000 JPY
59,877,000 JPY
Total number of issued shares
6,298,500 xbrli:shares
5,522,200 xbrli:shares
5,380,700 xbrli:shares
Net assets
2,361,483,000 JPY
2,021,702,000 JPY
2,632,614,000 JPY
Total assets
2,844,699,000 JPY
2,618,657,000 JPY
3,048,096,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-29.53
-158.46
-29.34
Diluted earnings per share
Equity-to-asset ratio
0.827 xbrli:pure
0.766 xbrli:pure
0.862 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.